drugset / Trial / NCT00823524
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
Phase 1/2
Completed
47 enrolled
Asan Medical Center
Korea Research Institute of Bioscience & Biotechnology · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Giving an infusion of natural killer cells from a donor after a donor stem cell transplant may help kill any remaining cancer cells after the transplant. PURPOSE: This phase I/II trial is studying the side effects and best dose of donor natural killer cells when given after a donor stem cell transplant in treating patients with advanced cancer.
Timeline
- Start
- 2009-01
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donor Natural Killer (NK) cells | Cell therapy | — | — |